What is Myomo Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Myomo's interest expense for the
three
months ended in Mar. 2024 was $ 0.00 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Myomo's Operating Income for the
three
months ended in Mar. 2024 was $ -3.89 Mil. Myomo's Interest Expense for the
three
months ended in Mar. 2024 was $ 0.00 Mil.
GuruFocus does not calculate Myomo's interest coverage with the available data.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Myomo Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Myomo (AMEX:MYO) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Myomo's Interest Expense for the
three
months ended in Mar. 2024 was $0.00 Mil. Its
Operating Income
for the
three
months ended in Mar. 2024 was $-3.89 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Mar. 2024 was $0.07 Mil.
Myomo's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as
| GuruFocus does not calculate Myomo's interest coverage with the available data. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Myomo Inc has enough cash to cover all of its debt. Its financial situation is stable.
Myomo (MYO) Business Description
Traded in Other Exchanges
Address
137 Portland Street, 4th Floor, Boston, MA, USA, 02114
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the device to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
Executives
| Thomas F Kirk |
director |
|
| Milton Mayo Morris |
director |
2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019 |
| Paul R Gudonis |
director, officer: Chief Executive Officer |
9 HICKORY ROAD, MANCHESTER MA 01944 |
| David A Henry |
officer: Chief Financial Officer |
|
| Harry Kovelman |
officer: Chief Medical Officer |
C/O MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114 |
| Yitzchak Jacobovitz |
director |
MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114 |
| Micah Mitchell |
officer: Chief Commercial Officer |
C/O MYOMO, INC., ONE BROADWAY 14TH FLOOR, CAMBRIDGE MA 02139 |
| Crowley Thomas Aloysius Jr. |
director |
19 ST CLAIR AV, SPRING LAKE NJ 07762 |
| Cliff Conneighton |
officer: Chief Marketing Officer |
53 DEPOT ROAD, HOLLS NH 03049 |
| Jonathan Naft |
officer: VP, General Manager |
C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142 |
| Brandon M Green |
officer: Chief Medical Officer |
C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142 |
| Ralph A Goldwasser |
officer: Chief Financial Officer |
BNN CORP, 150 CAMBRIDGEPARK DRIVE, CAMBRIDGE MA 02140 |
| Davie Mendelsohn |
officer: VP, Sales |
C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142 |
| Steve Sanghi |
director |
2355 W CHANDLER BLVD, CHANDLER AZ 85224-6199 |
| Amy K. Knapp |
director |
75 N. MOUNTAIN AVE, MONTCLAIR NJ 07042 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MYO has been successfully added to your 